ID

36643

Description

Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00953225

Link

https://clinicaltrials.gov/show/NCT00953225

Keywords

  1. 1/17/19 1/17/19 -
  2. 5/27/19 5/27/19 -
  3. 5/29/19 5/29/19 -
Copyright Holder

VA Office of Research and Development

Uploaded on

May 27, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Vitamin D Supplementation in Early-Stage Prostate Cancer NCT00953225

Eligibility Criteria

  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male veterans (> 18 years of age)
Description

Gender, age and veteran status

Data type

boolean

Alias
UMLS CUI [1]
C0042610
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0001779
recently diagnosed with low-risk pca (histologically documented adenocarcinoma of the prostate)
Description

recently diagnosed with histologically documented adenocarcinoma of the prostate, risk-assessed

Data type

boolean

Alias
UMLS CUI [1,1]
C0019638
UMLS CUI [1,2]
C0007112
UMLS CUI [1,3]
C0332185
UMLS CUI [2]
C0086930
a serum psa value of up to 10.0 ng/ml, and a gleason score of six or less (three or less in either architectural pattern)
Description

PSA and Gleason Score

Data type

boolean

Alias
UMLS CUI [1]
C0201544
UMLS CUI [2]
C3203027
serum creatinine 2.0 mg/dl
Description

Serum creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0201976
serum phosphate (measured as phosphorus) > 2.3 and < 4.8 mg/dl
Description

serum phosphate

Data type

boolean

Alias
UMLS CUI [1]
C1883013
serum calcium > 8.5 and < 10.5 mg/dl
Description

serum calcium

Data type

boolean

Alias
UMLS CUI [1]
C0728876
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects with any concurrent malignancy, except non-melanoma skin cancer
Description

concurrent malignancy except non-melanoma skin cancer

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
subjects with a history of sarcoidosis
Description

history of sarcoidosis

Data type

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0036202
subjects with a history of high-dose (1,000 IU per day) vitamin D supplementation
Description

history of vitamin D supplementation

Data type

boolean

Alias
UMLS CUI [1,1]
C4524013
UMLS CUI [1,2]
C0262926
UMLS CUI [2]
C0178602
subjects with a history of hypercalcemia
Description

history of hypercalcemia

Data type

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0020437
subjects who use lithium as a medication
Description

use of lithium

Data type

boolean

Alias
UMLS CUI [1,1]
C0023870
UMLS CUI [1,2]
C0013216

Similar models

Eligibility Criteria

  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender, age and veteran status
Item
male veterans (> 18 years of age)
boolean
C0042610 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
recently diagnosed with histologically documented adenocarcinoma of the prostate, risk-assessed
Item
recently diagnosed with low-risk pca (histologically documented adenocarcinoma of the prostate)
boolean
C0019638 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0086930 (UMLS CUI [2])
PSA and Gleason Score
Item
a serum psa value of up to 10.0 ng/ml, and a gleason score of six or less (three or less in either architectural pattern)
boolean
C0201544 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
Serum creatinine
Item
serum creatinine 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
serum phosphate
Item
serum phosphate (measured as phosphorus) > 2.3 and < 4.8 mg/dl
boolean
C1883013 (UMLS CUI [1])
serum calcium
Item
serum calcium > 8.5 and < 10.5 mg/dl
boolean
C0728876 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
concurrent malignancy except non-melanoma skin cancer
Item
subjects with any concurrent malignancy, except non-melanoma skin cancer
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
history of sarcoidosis
Item
subjects with a history of sarcoidosis
boolean
C0262926 (UMLS CUI [1,1])
C0036202 (UMLS CUI [1,2])
history of vitamin D supplementation
Item
subjects with a history of high-dose (1,000 IU per day) vitamin D supplementation
boolean
C4524013 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0178602 (UMLS CUI [2])
history of hypercalcemia
Item
subjects with a history of hypercalcemia
boolean
C0262926 (UMLS CUI [1,1])
C0020437 (UMLS CUI [1,2])
use of lithium
Item
subjects who use lithium as a medication
boolean
C0023870 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial